It is sad. @DrJBhattarcharya is the worst example I have personally seen of someone who was previously a scholar but who now engages in repeated misrepresentation of scientific results to serve a partisan agenda.
I recently testified pro bono in a trial about masking in schools (in my view, a complex question) for the sole purpose of explaining that the court should not trust @DrJBhattarcharya because he is deliberately misleading people about our study and others.
The judge disallowed him as an expert witness because of his repeated misrepresentations:
He now summarizes our study in Newsweek by saying, "In a study in Bangladesh, the 95 percent confidence interval showed that masks reduced transmission between 0 percent and 18 percent. Hence, masks are either of zero or limited benefit."
This is an absurd mischaracterization of our results as Jay is well aware. What does it get wrong?
1) We can rule out a zero effect w/ a p-value of .032 in the specification to which Jay refers
2) This is the *reduced form* from an increase in masking from 13% to 42%; so universal masking might be several times as effective
3) The CI for Covid symptoms is a 7-17% reduction (from our 30 pp increase in masking).
4) Our standard errors for symptomatic seropositivity drop by half under alternative (equally plausible) ways of imputing missing values, w/ a CI of 6-20%.
5) We have precise estimates for symptoms and symptomatic seropositivity at older age groups, esp. for surgical masks, where the CI rules out less than a 15% reduction (and includes a 55% reduction)
6) We have cross-sectional evidence showing that villages with larger increases in mask-wearing had larger reductions in symptoms and symptomatic seropositivity, in line w/ our other estimates.
Jay knows all of this since I messaged him privately to correct his misrepresentations, and he saw it all again when I testified in the trial to correct his misrepresentations but he keeps repeating his misleading statements in public forums.
Despite admitting to me in private correspondence that focusing on the absolute reduction in risk was misleading relative to the proportional reduction, he did *exactly this* in the court case before he knew I would be there to correct him.
His assessment of the DANMASK trial as showing that masks are ineffective is also equally misleading as I explained in my declaration to the court.
This experience casts in a new and more sinister light Jay's past policy mistakes, such as his claim that Covid mortality was substantially lower than epidemiologists believed and so Covid would lead to fewer deaths than a typical flu season: wsj.com/articles/is-th…
Policy issues are complex and difficult -- some of the best scientists (e.g. @ProfEmilyOster) look at the data for themselves and reach conclusions that are at odds with many epidemiologists. This work is essential.
@DrJBhattarcharya's behavior is especially disgraceful because he has the credentials and appearance of a person doing this type of science, when in practice, he is engaged in sophistry to justify his predetermined conclusions.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Jason Abaluck

Jason Abaluck Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Jabaluck

30 Oct
Does health insurance save lives? While there are dozens of studies with a wide range of estimates, the best studies consistently suggest that the answer is yes and the magnitude is considerable.
I recently received a referee report on a grant application suggesting that the RAND and Oregon experiments demonstrated that insurance doesn't matter for physical health, so it seems like a thread is needed.
In 1993, a JAMA study showed that conditional on gender, race, and baseline age, education, income, employment status, uninsured people had 25% higher mortality.
jamanetwork.com/journals/jama/…
Read 25 tweets
20 Oct
A major difference between econ and epi is that econ is more authoritarian while epi is more democratic. This has positive and negative consequences @epiellie
Econ is authoritarian in the sense that well-respected senior economists are the gatekeepers to all the top journals. If you want your paper to be widely read, you need to get it past an editor who is a leading authority in a (usually) related field.
This means that for a methodological innovation to diffuse, only a few top people need to be convinced that it is worthwhile and they will ask for it as a condition of publication in the top journals.
Read 11 tweets
27 Sep
Good news everyone! I'm "a prominent economist".

But Twitter folks -- stop critiquing my calculation by pointing out that it makes assumptions and ignores factors.
That is what calculations of this nature do. I thought it was important to get a rough order of magnitude sense of how many people need to wear a mask in public areas to save one life in the US. I did the most reasonable calculation I could think of given the data available.
I would be very pleased to see other calculations -- for example, embedding our results in a structural model which figured out the long-run impact on deaths given a race between vaccines and natural immunity would be extremely interesting.
Read 7 tweets
16 Sep
It does seem a little sinister when I get threats from "a meeting of the Clans", but hey, at least I'll be "part of world history"
Incidentally, we found that masks reduced COVID symptoms for people under the age of 50 but imprecise zeros for serologically-confirmed COVID.
This could mean that masks are most effective at combatting other respiratory diseases for people under 50, or just that we have less precision when we restrict to serologically confirmed COVID.
Read 4 tweets
13 Sep
This is a very important point -- masks prevent COVID and are valuable in places where many people are dying of COVID. Currently, this is many places.

However, that doesn't mean that a cost-benefit analysis suggests, "everyone should wear masks until COVID is eradicated"
The value of masks in places where nearly everyone is vaccinated is clearly lower. Caution is necessary since, in many parts of the world, the vaccines being used have lower efficacy than in the US, meaning that masks likely have value on top of vaccines.
Additionally, masks may prevent breakthrough cases which may eventually spread to unvaccinated people. However, I haven't seen a quantitative calculation of the magnitude of this benefit -- it may be small.
Read 10 tweets
5 Sep
An intuitive way to grasp the effectiveness of masks: extrapolating from our results, every 600 people who wear masks for a year in public areas prevents 1 person from dying of COVID given status quo death rates in the US.
Note that this is *taking into account current vaccination rates in the US*. Despite the availability of vaccines in the US, the weekly death rate is higher than at any point prior to November 2020.
Here is how I arrived at this number. Our study shows that inducing a 30 pp increase in mask-use prevented 35% of COVID cases among the elderly.
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(